Spero Therapeutics, Inc.
NASDAQ:SPRO
0.725 (USD) • At close April 21, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||
| Nettowinst
| -68.566 | 22.806 | -46.415 | -89.756 | -78.28 | -60.925 | -41.662 | -39.886 | -32.641 | -13.153 |
| Afschrijvingen & Amortisatie
| 0.002 | 0.367 | 0.869 | 0.646 | 0.761 | 0.75 | 0.409 | 0.363 | 0.279 | 0.011 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0.06 | -0.362 | -0.808 | 0 | 0.083 | -0.58 | -0.174 |
| Aandelen Gebaseerde Vergoedingen
| 7.793 | 7.932 | 9.123 | 9.43 | 4.888 | 3.776 | 2.749 | 1.427 | 0.18 | 0.021 |
| Verandering in Werkkapitaal
| 36.284 | -70.375 | 22.087 | 12.901 | -13.392 | 6.831 | -1.071 | 0.443 | -0.792 | 0.17 |
| Vorderingen
| 0 | 0 | 1.547 | 3.832 | 2.176 | -7.085 | 1.405 | -2.518 | -0.294 | -0.01 |
| Voorraden
| 0 | 0 | -1.547 | -3.832 | -2.176 | 7.085 | 0 | 0 | 0 | 0 |
| Crediteuren
| 5.928 | 0.761 | -0.484 | -0.053 | -2.975 | 0.564 | 0.084 | 2.349 | -0.644 | 0.671 |
| Overig Werkkapitaal
| 30.356 | -71.136 | 22.571 | 12.954 | -10.417 | 6.267 | -1.155 | -1.906 | -0.148 | -0.501 |
| Overige Niet-Contante Posten
| 1.043 | 6.275 | 6.605 | 2.372 | 0.513 | 0.356 | -0.05 | -1.541 | 4.595 | 3.517 |
| Kasstroom uit Operationele Activiteiten
| -23.444 | -32.995 | -7.731 | -64.347 | -85.872 | -50.02 | -39.625 | -39.111 | -28.959 | -9.608 |
| Investeringsactiviteiten: | ||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | 0 | 0 | 0.039 | -0.157 | -0.314 | -2.436 | -0.027 | -0.83 | -0.232 |
| Netto Overnames
| 0 | 0 | 0 | -0.039 | -10.627 | -29.844 | 83.156 | -1.175 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | -26.97 | -43.915 | -45.723 | -88.993 | -130.175 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 60.777 | 51.548 | 56.35 | 118.837 | 49.455 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 33.807 | 0.039 | 10.627 | 29.844 | -83.156 | -0.027 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | 0 | 33.807 | 7.672 | 10.47 | 29.53 | -83.156 | -0.027 | -0.83 | -0.232 |
| Financieringsactiviteiten: | ||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0.221 | 24.512 | 35.368 | 78.66 | 15.79 | 70.5 | 77.749 | 34.413 | 15.305 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0 | 0 | -54.065 | 48.682 | 52.221 | 0.35 | -0.977 | 38.362 | 34.413 | 15.275 |
| Kasstroom uit Financieringsactiviteiten
| 0 | 0.221 | -29.553 | 84.05 | 130.881 | 16.14 | 69.523 | 116.111 | 34.413 | 15.275 |
| Overige Informatie: | ||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -23.444 | -32.774 | -3.477 | 27.375 | 55.479 | -4.35 | -53.258 | 76.973 | 4.624 | 5.435 |
| Kaspositie aan het Einde van de Periode
| 52.889 | 76.333 | 109.107 | 112.584 | 85.209 | 29.73 | 34.08 | 87.288 | 10.315 | 5.691 |